iSpecimen (ISPC) Total Current Liabilities (2020 - 2026)

iSpecimen's Total Current Liabilities history runs 7 years deep, the most recent figure standing at $5.6 million for Q1 2026.

• In Q1 2026, Total Current Liabilities rose 13.82% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $5.6 million (up 13.82% YoY), while the FY2025 annual figure was $6.2 million, up 7.99% from the prior year.
• Total Current Liabilities was $5.6 million for Q1 2026 at iSpecimen, down from $6.2 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $6.3 million in Q3 2024 to a low of $2.0 million in Q2 2022.
• Historically, Total Current Liabilities has averaged $4.6 million across 5 years, with a median of $5.2 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Total Current Liabilities sank 65.75% in 2022, then jumped 103.25% in 2024.
• A 5-year view of Total Current Liabilities shows it stood at $4.3 million in 2022, then surged by 41.29% to $6.0 million in 2023, then fell by 4.6% to $5.8 million in 2024, then rose by 7.99% to $6.2 million in 2025, then declined by 10.14% to $5.6 million in 2026.
• The last three Total Current Liabilities figures came in at $5.6 million (Q1 2026), $6.2 million (Q4 2025), and $5.7 million (Q3 2025), per Business Quant data.